Korean Translation of the GRADE Series Published in the BMJ, ‘GRADE: Grading Quality of Evidence and Strength of Recommendations for Diagnostic Tests and Strategies’ (A Secondary Publication)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This article is the fourth translation of a GRADE series published in the BMJ, which graded the quality of evidence and strength of recommendations for diagnostic tests or strategies, as a comprehensive and transparent approach for developing re-commendations. Randomized trials for diagnostic approaches represent the ideal study design for intervention studies. On the other hand, cross-sectional or cohort studies with a direct comparison of the test results with an appropriate reference standard can provide high-quality evidence. The guideline panel must be reminded that the test accuracy is a surrogate for patient-important outcomes, so such studies often provide a low quality of evidence for recommendations regarding diagnostic tests, even when the studies do not have serious limitations. Diagnostic accuracy studies showing that a diagnostic test or strategy improves important patient outcomes will require the availability of effective treatment, reduction of test- related adverse effects or anxiety, or improvement of the patients’ well-being from prognostic information. Therefore, it is important to assess the directness of the test results regarding the consequences of diagnostic recommendations that are im-portant to patients.
Abstract
This article is the fourth translation of a GRADE series published in the BMJ, which graded the quality of evidence and strength of recommendations for diagnostic tests or strategies, as a comprehensive and transparent approach for developing re-commendations. Randomized trials for diagnostic approaches represent the ideal study design for intervention studies. On the other hand, cross-sectional or cohort studies with a direct comparison of the test results with an appropriate reference standard can provide high-quality evidence. The guideline panel must be reminded that the test accuracy is a surrogate for patient-important outcomes, so such studies often provide a low quality of evidence for recommendations regarding diagnostic tests, even when the studies do not have serious limitations. Diagnostic accuracy studies showing that a diagnostic test or strategy improves important patient outcomes will require the availability of effective treatment, reduction of test- related adverse effects or anxiety, or improvement of the patients’ well-being from prognostic information. Therefore, it is important to assess the directness of the test results regarding the consequences of diagnostic recommendations that are im-portant to patients.
참고문헌 (28)
- Deeks JJ, "Systematic reviews in health care : systematic reviews of evaluations of diagnostic and screening tests", BMJ, 323, pp.157~162 (2001)
- Oxman AD, "Guidelines for reading literature reviews", CMAJ, 138, pp.697~703 (1988)
- Mulrow CD, "Assessing quality of a diagnostic test evaluation", J Gen Intern Med, 4, pp.288~295 (1989)
- Guyatt G, "Patients at the center : in our practice, and in our use of language", ACP J Club, 140, pp.A11~A12 (2004)
- Hamon M, "Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis", J Am Coll Cardiol, 48, pp.1896~1910 (2006)
- Bossuyt PM, "Comparative accuracy : assessing new tests against existing diagnostic pathways", BMJ, 332, pp.1089~1092 (2006)
- Bossuyt PM, "Randomised comparisons of medical tests : sometimes invalid, not always efficient", Lancet, 356, pp.1844~1847 (2000)
- Mueller C, "Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea", N Engl J Med, 350, pp.647~654 (2004)
- Moe GW, "N-terminal pro-Btype natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVECHF study", Circulation, 115, pp.3103~3110 (2007)
- Worster A, "The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis : a meta-analysis", Ann Emerg Med, 40, pp.280~286 (2002)
- Worster A, "Does replacing intravenous pyelography with noncontrast helical computed tomography benefit patients with suspected acute urolithiasis?", Can Assoc Radiol J, 53, pp.144~148 (2002)
- Schünemann HJ, "Grading quality of evidence and strength of recommendations for diagnostic tests and strategies", BMJ, 336, pp.1106~1110 (2008)
- Guyatt GH, "Going from evidence to recommendations", BMJ, 336, pp.1049~1051 (2008)
- Guyatt GH, "What is “quality of evidence” and why is it important to clinicians?", BMJ, 336, pp.995~998 (2008)
- Lord SJ, "When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?", Ann Intern Med, 144, pp.850~855 (2006)
- Maat-Kievit A, "Paradox of a better test for Huntington’s disease", J Neurol Neurosurg Psychiatry, 69, pp.579~583 (2000)
- Walker FO, "Huntington’s disease", Semin Neurol, 27, pp.143~150 (2007)
- Almqvist EW, "Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease", Clin Genet, 64, pp.300~309 (2003)
- Rutjes AW, "Evidence of bias and variation in diagnostic accuracy studies", CMAJ, 174, pp.469~476 (2006)
- Lijmer JG, "Empirical evidence of design-related bias in studies of diagnostic tests", JAMA, 282, pp.1061~1066 (1999)
- Bossuyt PM, "Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative", Ann Intern Med, 138, pp.40~44 (2003)
- Whiting P, "The development of QUADAS : a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews", BMC Med Res Methodol, 3, pp.25~ (2003)
- Whiting PF, "Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies", BMC Med Res Methodol, 6, pp.9~ (2006)
- Atkins D, "Grading quality of evidence and strength of recommendations", BMJ, 328, pp.1490~ (2004)
- Schünemann HJ, "An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations", Am J Respir Crit Care Med, 174, pp.605~614 (2006)
- Fletcher RH, "Carcinoembryonic antigen", Ann Intern Med, 104, pp.66~73 (1986)
- Hlatky MA, "Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis", Am J Med, 77, pp.64~71 (1984)
- Levy D, "Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy", Circulation, 81, pp.815~820 (1990)